Brunangelo Falini researcher
Falini, Brunangelo
VIAF ID: 9086155566448413380009 (Personal)
Permalink: http://viaf.org/viaf/9086155566448413380009
Preferred Forms
- 100 0 _ ‡a Brunangelo Falini ‡c researcher
- 100 1 _ ‡a Falini, Brunangelo
4xx's: Alternate Name Forms (3)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas. | |
Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas | |
In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML. | |
In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 | |
ins | |
ins(6;11) in a case of peripheral T-cell lymphoma | |
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas | |
IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. | |
Is histiocytic reticulosis an infectious disease? | |
Large cell lymphoma of bone. A report of three cases of B-cell origin | |
LF61: a new monoclonal antibody directed against a trimeric molecule (150 kDa, 125 kDa, 105 kDa) associated with hairy cell leukaemia. | |
Light chain plasmacytoid lymphocytic lymphoma. | |
Long noncoding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients | |
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study | |
Lymphoma classification: the quiet after the storm | |
Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. | |
Macrophages | |
Macrophages (phagocytic-histiocytic reticular cells) in reactive-inflammatory lesions of the bone marrow and in myelodysplastic syndromes (MDS). An immunohistochemical and morphometric study by use of a new monoclonal antibody (PG-M1) | |
Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study | |
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens | |
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML. | |
Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help. | |
Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia | |
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1) | |
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification | |
Mutational landscape of AML with normal cytogenetics: biological and clinical implications. | |
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients | |
New mechanism of lymphoma-induced bone marrow aplasia. | |
Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease. | |
Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers. | |
Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity | |
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia | |
NPM1-mutated AML: targeting by disassembling | |
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. | |
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations | |
Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA. | |
Nucleophosmin is required for DNA integrity and p19Arf protein stability | |
Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules | |
Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA | |
Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization. | |
Nucleophosmin regulates the stability and transcriptional activity of p53 | |
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis | |
Pathobiology of primary mediastinal B-cell lymphoma | |
Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling. | |
Phytohemagglutinin-conditioned medium modulates adherence properties and morphology of hairy cells | |
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia | |
Prolymphocytic leukaemia with erythrophagocytic activity | |
Protein A-peroxidase conjugates for two-stage immunoenzyme staining of intracellular antigens in paraffin-embedded tissues | |
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin | |
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients. | |
Rapid Diagnosis of Acute Promyelocytic Leukemia by Analyzing the Immunocytochemical Pattern of the PML Protein With the Monoclonal Antibody PG-M3 | |
Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin | |
Recent advances in understanding and managing hairy cell leukemia. | |
Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin | |
Response to intermediate and standard doses of IFN-beta in hairy-cell leukaemia | |
Rhabdomyosarcoma presenting as 'acute leukaemia' | |
A scale of "bad" co-mutations in NPM1-driven AML. | |
Sch proteins are localized on endoplasmic reticulum membranes and are redistributed after tyrosine kinase receptor activation. | |
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study. | |
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. | |
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family | |
Single and double immunoenzymatic techniques for labeling tissue sections with monoclonal antibodies | |
Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma | |
T-cell receptor beta-chain gene rearrangement in a case of Ph1-positive chronic myeloid leukemia blast crisis | |
T regulatory cell separation for clinical application. | |
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia | |
Therapy-related acute myeloid leukaemia with mutated NPM1: treatment induced or de novo in origin? | |
Topographical localization of intracellular immunoglobulins in hairy cells by immunoelectron microscopy | |
Transformation of IGHV4-34+ hairy cell leukaemia-variant with U2AF1 mutation into a clonally-related high grade B-cell lymphoma responding to immunochemotherapy | |
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias | |
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy | |
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI | |
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. | |
Tyrosine phosphorylation in human lymphomas. | |
Use of a panel of monoclonal antibodies for the diagnosis of hairy cell leukaemia. An immunocytochemical study of 36 cases. | |
Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies. | |
A western blot assay for detecting mutant nucleophosmin | |
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype |